Difference between revisions of "Part:BBa K2976006"
Line 8: Line 8:
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
−
===Usage and Biology===
+
===Characteristics===
 +
<p>Anti-PD-L1 peptide was designed as a fusion protein with lamp2 and HA tag. With the detection of HA tag, the expression of anti-PD-L1 was confirmed as well.
 +
</p>
  
 
<!-- -->
 
<!-- -->

Revision as of 13:44, 21 October 2019


Anti-PD-L1 peptide

Usage and Biology

Anti-PD-L1 peptide selectively binds to programmed death ligand 1 (PD-L1), an immune checkpoint protein that is overexpressed in many cancer cell lines. Recent study has demonstrated that the Mtb-infected macrophages express more PD-L1 than normal ones. Thus, PD-L1 could be a promising target for intracellular Mtb therapy. In 2019 CPU_CHINA project, anti-PD-L1 peptide is displayed on the surface of the exosome to specifically targeting the Mtb-infected macrophages.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]